<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is limited evidence for the association of specific <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1136085" disease_type="Neoplastic Process" abbrv="">Monoclonal gammopathies</z:e> can occur in RA </plain></SENT>
<SENT sid="2" pm="."><plain>Their predictive value for the development of a <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> remains unclear and disputed </plain></SENT>
<SENT sid="3" pm="."><plain>We reviewed charts of 214 RA patients <z:hpo ids='HP_0000001'>all</z:hpo> of whom had at least one serum protein electrophoresis </plain></SENT>
<SENT sid="4" pm="."><plain>We performed a retrospective study of 12 patients with RA and an M spike </plain></SENT>
<SENT sid="5" pm="."><plain>We further characterized the M spike by serum immunofixation and bone marrow studies </plain></SENT>
<SENT sid="6" pm="."><plain>The median age at which the M spike was identified was 69 years </plain></SENT>
<SENT sid="7" pm="."><plain>IgG was the predominant <z:e sem="disease" ids="C0178650" disease_type="Disease or Syndrome" abbrv="">gammopathy</z:e> in 50% of patients, with no difference in the amount of kappa (kappa) and lambda (lambda) chains </plain></SENT>
<SENT sid="8" pm="."><plain>One patient was diagnosed with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, one with an undefined primary <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo>, one with T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, five with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and four with <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of undetermined significance</z:e> at most recent evaluation </plain></SENT>
<SENT sid="9" pm="."><plain>Of our patients, 42% had a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, which has not been previously reported, and, in contrast to previous reports, no <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were identified </plain></SENT>
<SENT sid="10" pm="."><plain>The follow-up evaluation of patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:e sem="disease" ids="C0278494" disease_type="Neoplastic Process" abbrv="MGUS">monoclonal gammopathy of undetermined significance</z:e> is important because they may progress to an overt <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>